Journal Information
Vol. 44. Issue S1.
Pages S19 (October 2022)
Share
Share
Download PDF
More article options
Vol. 44. Issue S1.
Pages S19 (October 2022)
OP 12
Open Access
TREATMENT OF A PATIENT DIAGNOSED WITH ERDHEIM CHESTER'S DISEASE IN COOPERATION WITH PLASTIC SURGERY AND HEMATOLOGY
Visits
551
Simge ERDEM1, Dilek Özden ÖZLÜK1, Erol KOZANOĞLU2, Sevgi KALAYOĞLU BEŞIŞIK1
1 Istanbul University Istanbul Faculty of Medicine, Department of Internal Medicine, Division of Hematology
2 Istanbul University Istanbul Faculty of Medicine, Department of Plastic and Reconstructive Surgery
This item has received

Under a Creative Commons license
Article information
Special issue
This article is part of special issue:
Vol. 44. Issue S1
More info
Objective

Erdheim Chester disease (ECD) is a rare non-Langerhans histiocytic multisystem disorder. ECD is most commonly manifested as multifocal sclerotic long bone lesions. Orbital and intraocular manifestations are rare. We report an unusual bilateral orbital presentation as xanthomatous infiltration of ECD.

Case report

A 56-year-old male was admitted due to papular lesions on both eyelids. Eyelid tissue histology showed histiocytic infiltration consistent with ECD. BRAF V600E mutation (-). In the first year, PET-CT showed new lesions on the lymph node, eyelids, knees and elbows. Laboratory investigation was within normal apart of mild increased CRP. The disorder was unresponsive to pegylated interferon alfa. With cladribine of 3 courses and surgical intervention he achieved a nearly normal facial appearance.

Conclusion

Uncontrolled cell survival, differentiation, and proliferation of histiocytes in ECD result in soft tissue thickening and progressed to chronic fibrotic disease which may be unresponsive to medical treatments and requires surgical interventions.

Full text is only aviable in PDF
Idiomas
Hematology, Transfusion and Cell Therapy
Article options
Tools